- Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Carla Casulo
Memorial Sloan Kettering Cancer Center, New York, NY 10165, USA
Curr Oncol Rep 12:374-82. 2010..This article seeks to review the literature on the role of ASCT in PTCL, as well as to clarify what may be the optimal disease state in which to offer patients with PTCL autologous transplantation, if at all...
- 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphomaCarla Casulo
Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Leuk Lymphoma 54:2163-7. 2013..Interim FDG-PET may predict for PFS. FDG-PET should be integrated into prospective trials to confirm these findings...